Does TOFACITINIB Cause Peripheral venous disease? 993 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 993 reports of Peripheral venous disease have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.6% of all adverse event reports for TOFACITINIB.
993
Reports of Peripheral venous disease with TOFACITINIB
0.6%
of all TOFACITINIB reports
832
Deaths
852
Hospitalizations
How Dangerous Is Peripheral venous disease From TOFACITINIB?
Of the 993 reports, 832 (83.8%) resulted in death, 852 (85.8%) required hospitalization, and 865 (87.1%) were considered life-threatening.
Is Peripheral venous disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 993 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Peripheral venous disease?
RITUXIMAB (1,281)
ADALIMUMAB (1,249)
METHOTREXATE (1,246)
SECUKINUMAB (1,186)
ABATACEPT (1,168)
DICLOFENAC (1,168)
LEFLUNOMIDE (1,154)
TOCILIZUMAB (1,137)
PREDNISONE (1,101)
ALENDRONATE (1,097)
Which TOFACITINIB Alternatives Have Lower Peripheral venous disease Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN